Table: begin end state 1 12 non-cytoplasmic 13 80 transmembrane 81 108 non-cytoplasmic 109 135 transmembrane 136 137 non-cytoplasmic 138 146 cytoplasmic 147 163 transmembrane 164 168 non-cytoplasmic 169 188 transmembrane 189 199 cytoplasmic 200 223 transmembrane 224 257 non-cytoplasmic 258 258 cytoplasmic 259 280 transmembrane 281 315 cytoplasmic 316 337 transmembrane 338 355 non-cytoplasmic 356 381 transmembrane 382 390 cytoplasmic 391 409 transmembrane 410 418 non-cytoplasmic 419 444 transmembrane 445 463 cytoplasmic 464 488 transmembrane 489 505 non-cytoplasmic
Input: >WP_011842395.1 NCBI__GCF_000015985.1:WP_011842395.1 MGTFDFLLQGLAVALDPMILLYALVGVTLGTAVGVLPGIGPALTVALLLPVTYGLDPAGS LIMFAGIYYGGMYGGSTTSILLNTPGESASIVTALEGNKMARAGRGGPALATAAIGSFVA GLLATIALALIAPTVVKLALVFGPREYFALMVLAFVTVSAAFGDSTLRGLTSLFIGLALA VVGIDQLTGQARLSFGVPQLLDGIEVTTLAVALFAVGEALFVAGRGMHRDDEAIAVKGSL WMTAQDWARSWKSWLRGTVIGFPIGAMPAGGADIASFLSYATEKRFSRHPEEFGHGAIEG VAGPEAANNASAAGTLVPLLTLGLPTTATAAIMLAGFQQFGLQPGPLLFATNPQLVWGLI ASLLIANVMLLVLNLPLIGLWVRLLTIPRPWLYAGILLFATLGTIGVNPSPVELGMLLGF GVLGYLMRLFSYPIAPVVVGLILGPMAEQQLRRALAIAQGDVTTLIASPIAATLLGLAAA ALIVPILMRRYGRGDILVKIAADED
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server